Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/01/2014WO2014066795A1 Heterocyclic compounds for the inhibition of pask
05/01/2014WO2014066745A1 Compositions comprising polyethylene glycol in the therapy of head and neck squamous cell carcinoma
05/01/2014WO2014066743A1 Heterocyclic compounds for the inhibition of pask
05/01/2014WO2014066726A2 Compounds for modulating il-17
05/01/2014WO2014066695A1 Compositions and methods for treating estrogen-related medical disorders
05/01/2014WO2014066692A1 Compositions and methods for treating estrogen-related medical disorders
05/01/2014WO2014066686A1 Brain targets for neurotrophic factors to treat neurodegenerative disease
05/01/2014WO2014066659A1 Heteroaryl inhibitors of pde4
05/01/2014WO2014066658A1 Ketorolac-containing sustained release drug delivery systems
05/01/2014WO2014066653A1 Ketorolac-containing sustained release intraocular drug delivery systems
05/01/2014WO2014066644A1 Ketorolac-containing sustained release drug delivery systems
05/01/2014WO2014066636A1 Controlled application of cross-linking agent
05/01/2014WO2014066606A2 Combination
05/01/2014WO2014066585A1 Compositions and methods for transdermal delivery of amphetamine
05/01/2014WO2014066502A2 Flavivirus protease inhibitors
05/01/2014WO2014066498A1 Treatment of metastatic breast cancer
05/01/2014WO2014066491A1 N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels
05/01/2014WO2014066490A1 Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
05/01/2014WO2014066485A1 Stable preservative-free mydriatic and anti-inflammatory solutions for injection
05/01/2014WO2014066442A2 Methods of managing childhood cerebral injury
05/01/2014WO2014066435A1 Etp derivatives
05/01/2014WO2014066400A2 Methods for the effective treatment of metastatic cancer
05/01/2014WO2014066330A1 Compositions and methods for treating mammary tumors
05/01/2014WO2014066320A1 Benzenetricarboxylic acid and methods of use
05/01/2014WO2014066318A1 Combination therapies for the treatment of alzheimer's disease and related disorders
05/01/2014WO2014066304A1 Compositions and methods for treating or preventing diseases or disorders associated with misregulated eif4e
05/01/2014WO2014066297A1 Nonwoven fiber materials
05/01/2014WO2014066243A1 Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}
05/01/2014WO2014066225A1 Low toxicity topical active agent delivery system
05/01/2014WO2014066212A1 Medicinal treatment of dermal diseases in companion animals with norketotifen
05/01/2014WO2014066204A1 Combination
05/01/2014WO2014066202A1 Combination
05/01/2014WO2014066196A1 2-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonists
05/01/2014WO2014066151A1 Aggrecanase inhibitors
05/01/2014WO2014066137A1 Compositions and methods for enhancing cancer immunotherapy
05/01/2014WO2014066132A1 Bace inhibitors
05/01/2014WO2014066082A1 Blocking activities of e6ap ligase
05/01/2014WO2014065860A1 Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions
05/01/2014WO2014065791A1 Hepatitis c virus inhibitors
05/01/2014WO2014065772A1 Agent for healing wounds of various etiologies and method for the use thereof
05/01/2014WO2014065770A1 Concerns the eliminates the effect of the local anesthesia to soft tissue with ondansetrone
05/01/2014WO2014065769A1 Formulations for oral suspensions comprising antibiotics
05/01/2014WO2014065751A1 Lyophilized preparations of melphalan flufenamide
05/01/2014WO2014065710A1 (3-arylsulfonyl-quinoline-8-yl)-dialkyl-amines as selective antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
05/01/2014WO2014065575A1 4,5-dihydro-1h-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same
05/01/2014WO2014065572A1 Pharmaceutical composition for preventing or treating cancer, containing enoblock as active ingredient
05/01/2014WO2014065545A1 Pharmaceutical composition containing lobarstin for preventing or treating brain cancer and combined therapy for treating brain cancer using same
05/01/2014WO2014065537A1 Pharmaceutical composition for preventing and treating prostate cancer
05/01/2014WO2014065510A1 Novel rotenone derivatives and a use thereof
05/01/2014WO2014065440A1 Cancer cell inhibitory drug and cancer stem-cell detection probe
05/01/2014WO2014065439A1 Cancer cell inhibitory drug and cancer stem-cell detection probe
05/01/2014WO2014065437A1 Prophylactic and/or therapeutic agent for behavioral and psychological symptoms associated with neurodegenerative disease or impulsive symptoms associated with mental disease containing brexpiprazole or salt thereof
05/01/2014WO2014065434A1 Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
05/01/2014WO2014065427A1 Anagliptin-containing solid pharmaceutical preparation
05/01/2014WO2014065413A1 Triazole-isoxazole compound and medical use thereof
05/01/2014WO2014065390A1 Method for suppressing deposition of menthol whiskers
05/01/2014WO2014065374A1 Therapeutic or prophylactic agent for retinopathy of prematurity, method of testing for retinopathy of prematurity, and screening method for therapeutic or prophylactic substance for retinopathy of prematurity
05/01/2014WO2014065370A1 Pulmonary hypertension therapeutic agent
05/01/2014WO2014065297A1 Silicon-containing compound aqueous solution and antibacterial/antiviral agent including said solution
05/01/2014WO2014065275A1 Therapeutic or prophylactic agent for tumor lysis syndrome
05/01/2014WO2014065270A1 Tetrahydrooxazolo-pyridine derivative
05/01/2014WO2014065229A1 Adjuvant and vaccine including same
05/01/2014WO2014065209A1 Pyridine compound or salt thereof, pest control agent, insecticide or acaricide, and ectoparasite control agent
05/01/2014WO2014065194A1 Nerve growth inhibitor, cutaneous-sensory-irritation inhibitor, and marker for cutaneous-sensory-irritation detection
05/01/2014WO2014064811A1 Pulmonary hypertension therapeutic agent
05/01/2014WO2014064717A1 Stable pharmaceutical composition of 5-αζα-2'ρεοχυοτιρινε
05/01/2014WO2014064703A1 Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
05/01/2014WO2014064697A1 Method of treatment of disease
05/01/2014WO2014064654A1 Derivatives of camptothecin, a method of producing them and their use
05/01/2014WO2014064632A1 Dermal injectable sterile composition
05/01/2014WO2014064630A1 Pharmaceutical composition for reducing the trimethylamine n-oxide level
05/01/2014WO2014064566A1 Use of a tetrasubstituted pyrazolo[4,3-d]pyrimidine compound for treating diabetic nephropathy
05/01/2014WO2014064409A1 Pharmaceutical antiretroviral composition
05/01/2014WO2014064391A1 Polymer of hyaluronate and of glucomannan
05/01/2014WO2014064258A1 Compositions and methods for selective delivery of oligonucleotide molecules to cell types
05/01/2014WO2014064257A1 Compositions and methods for the treatment of parkinson disease by the selective delivery of oligonucleotide molecules to specific neuron types
05/01/2014WO2014064215A1 TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING β-CELL SURVIVAL
05/01/2014WO2014064191A2 Drug combinations and uses
05/01/2014WO2014064166A1 Mixed inhibitors of aminopeptidase n and of neprilysine
05/01/2014WO2014064162A1 Neprilysin inhibitors
05/01/2014WO2014064149A1 4-carboxamido-isoindolinone derivatives as selective parp-1 inhibitors
05/01/2014WO2014064134A1 3,4-disubstituted 1 h-pyrazole and 4,5-disubstituted thiazole inhibitors of syk
05/01/2014WO2014064118A1 Triazine derivatives for the treatment of conditions associated with nicotinamide adenine dinucleotide phosphate oxidase
05/01/2014WO2014064077A1 Crystalline phase of (3s.3s') 4,4'-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine
05/01/2014WO2014064038A1 Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine d3 receptor
05/01/2014WO2014064030A1 Stable injectable composition containing diclofenac and thiocolchicoside
05/01/2014WO2014064028A1 Mglu2/3 antagonists for the treatment of autistic disorders
05/01/2014WO2014063923A1 Quinone based nitric oxide donating compounds for ophthalmic use
05/01/2014WO2014063868A1 Galactagogue compositions based on phosphatidylserine
05/01/2014WO2014063778A1 2-aminopyridine compounds
05/01/2014WO2014063660A1 Naringenin and asiatic acid combination treatment of fibrosis
05/01/2014WO2014063659A1 Treatment of cancer using a smad3 inhibitor
05/01/2014WO2014063631A1 Tyrosine kinase irreversible inhibitor and preparation method and applications thereof
05/01/2014WO2014063597A1 New cycloalkylamine compound useful in resisting mutant influenza virus
05/01/2014WO2014063596A1 Oral formulation for treating diabetes
05/01/2014WO2014063587A1 Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereof
05/01/2014WO2014063477A1 Application of harmine derivatives in preparation of antimicrobial agents
05/01/2014WO2014063441A1 Triterpene derivative and its anti-influenza use
05/01/2014WO2014063312A1 Use of salvianolic acid a in prevention and/or treatment of cerebral microvascular thromboembolic disease
05/01/2014WO2014063205A1 Use of endocytosis inhibitors and antibodies for cancer therapy
1 ... 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 ... 7860